# ZNF419

## Overview
ZNF419 is a gene that encodes the zinc finger protein 419, which is categorized as a transcriptional regulator. This protein is characterized by its zinc finger domains, which enable it to bind specific DNA sequences and regulate gene expression. ZNF419 is involved in various cellular processes, including cell differentiation and development, and plays a role in immune system interactions, particularly in inflammatory environments. Although its expression is generally low in normal tissues, ZNF419 is implicated in cancer biology, where it influences immune cell infiltration and tumor progression. The gene's polymorphisms can lead to the production of unique peptides recognized by cytotoxic T lymphocytes, suggesting its potential involvement in immune surveillance and as a target for cancer immunotherapy (Zhu2022A; Broen2011A).

## Function
ZNF419, a zinc finger protein, functions primarily as a transcriptional regulator in the nucleus, where it influences gene expression by binding to specific DNA sequences. This protein is involved in various cellular processes, including cell differentiation and development, by modulating the transcription of target genes (Geng2017Persistent). Although the specific function of ZNF419 in healthy human cells is not extensively detailed, its expression is generally low across various hematopoietic and non-hematopoietic tissues, such as fibroblasts, keratinocytes, and proximal tubular epithelial cells (Broen2011A). 

In the context of immune recognition, ZNF419 is associated with the production of a unique peptide due to a polymorphism in its splice donor site, which is recognized by cytotoxic T lymphocytes. This suggests a role in immune system interactions, particularly in inflammatory environments where its expression can be upregulated (Broen2011A). Despite its low expression in normal tissues, ZNF419's involvement in immune responses and potential upregulation under certain conditions indicate its significance in cellular processes related to immune surveillance and tumor recognition (Broen2011A).

## Clinical Significance
ZNF419 has been implicated in various cancers due to its altered expression levels and interactions. High expression of ZNF419 is associated with poor prognosis in several cancers, including prostate adenocarcinoma (PRAD), kidney renal clear cell carcinoma (KIRC), liver hepatocellular carcinoma (LIHC), lung squamous cell carcinoma (LUSC), and bladder urothelial carcinoma (BLCA) (Zhu2022A). Conversely, low expression of ZNF419 is linked to shorter overall survival in rectal adenocarcinoma (READ) and BLCA (Zhu2022A). The gene's expression is also related to tumor heterogeneity and immune response, influencing tumor mutation burden (TMB) and microsatellite instability (MSI) (Zhu2022A).

In renal cell carcinoma (RCC), a polymorphism in the splice donor site of ZNF419 results in the creation of a novel minor histocompatibility antigen (MiHA) named ZAPHIR. This antigen is recognized by cytotoxic T lymphocytes, suggesting a role in immune surveillance and potential for targeted immunotherapy (Broen2011A). The presence of ZAPHIR-specific CD8+ T cells in RCC and chronic myeloid leukemia (CML) patients indicates its involvement in graft-versus-tumor reactivity without causing graft-versus-host disease (Broen2011A). These findings highlight ZNF419's potential as a biomarker and therapeutic target in cancer treatment.

## Interactions
ZNF419, a zinc finger protein, is involved in various interactions that influence cancer biology. It is significantly correlated with FANCD2 in several cancer types, suggesting a regulatory role in ferroptosis, a form of regulated cell death (Zhu2022A). This interaction may mediate ZNF419's effects on ferroptosis and drug resistance, particularly in glioblastoma (Zhu2022A). 

The expression of ZNF419 is also associated with immune regulation and immune cell infiltration in the tumor microenvironment. It shows positive associations with immune cells such as B cells, CD8+ T cells, neutrophils, and macrophages in prostate adenocarcinoma, and CD4+ T cells and macrophages in lung squamous cell carcinoma (Zhu2022A). These interactions suggest that ZNF419 plays an immunosuppressive role, affecting the content of immune and stromal cells across various cancer types (Zhu2022A).

While ZNF419 is listed among the zinc finger proteins associated with wild-type TRIM28, specific interactions with TRIM28 or other proteins and nucleic acids are not detailed in the provided excerpts (Chang2023AcetylationMimic). Overall, ZNF419's interactions highlight its complex role in cancer progression and immune response.


## References


[1. (Geng2017Persistent) Fengxue Geng, Junchao Liu, Yan Guo, Chen Li, Hongyang Wang, Hongyan Wang, Haijiao Zhao, and Yaping Pan. Persistent exposure to porphyromonas gingivalis promotes proliferative and invasion capabilities, and tumorigenic properties of human immortalized oral epithelial cells. Frontiers in Cellular and Infection Microbiology, February 2017. URL: http://dx.doi.org/10.3389/fcimb.2017.00057, doi:10.3389/fcimb.2017.00057. This article has 78 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fcimb.2017.00057)

[2. (Zhu2022A) Weizhen Zhu, Dechao Feng, Xu Shi, Dengxiong Li, Qiang Wei, and Lu Yang. A pan-cancer analysis of the oncogenic role of zinc finger protein 419 in human cancer. Frontiers in Oncology, December 2022. URL: http://dx.doi.org/10.3389/fonc.2022.1042118, doi:10.3389/fonc.2022.1042118. This article has 7 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fonc.2022.1042118)

[3. (Broen2011A) Kelly Broen, Henriette Levenga, Johanna Vos, Kees van Bergen, Hanny Fredrix, Annelies Greupink-Draaisma, Michel Kester, J. H. Frederik Falkenburg, Pieter de Mulder, Theo de Witte, Marieke Griffioen, and Harry Dolstra. A polymorphism in the splice donor site of znf419 results in the novel renal cell carcinoma-associated minor histocompatibility antigen zaphir. PLoS ONE, 6(6):e21699, June 2011. URL: http://dx.doi.org/10.1371/journal.pone.0021699, doi:10.1371/journal.pone.0021699. This article has 25 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0021699)

[4. (Chang2023AcetylationMimic) Yao-Jen Chang, Steven Lin, Zhi-Fu Kang, Bin-Jon Shen, Wen-Hai Tsai, Wen-Ching Chen, Hsin-Pin Lu, Yu-Lun Su, Shu-Jen Chou, Shu-Yu Lin, Sheng-Wei Lin, Yin-Jung Huang, Hsin-Hui Wang, and Ching-Jin Chang. Acetylation-mimic mutation of trim28-lys304 to gln attenuates the interaction with krab-zinc-finger proteins and affects gene expression in leukemic k562 cells. International Journal of Molecular Sciences, 24(12):9830, June 2023. URL: http://dx.doi.org/10.3390/ijms24129830, doi:10.3390/ijms24129830. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms24129830)